We aimed to study the effect of buspirone, an anxiolytic drug and 5-HT 1A agonist on liver injury induced by carbon tetrachloride (CCl 4 ) in rats. Rats were orally treated with CCl 4 (2.8 mL/kg in olive oil) along with buspirone at 10, 20 or 30 mg/kg once daily starting with CCl 4 and for one week thereafter. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) as well as alkaline phosphatase (ALP) activities were determined in the serum. Markers of oxidative stress: lipid peroxidation (malondialdehyde; MDA), reduced glutathione (GSH), nitric oxide (nitrite/nitrate) levels were measured in the liver.
Introduction
Buspirone is a partial 5-HT 1A receptor agonist that is widely used in treating anxiety disorders and depression [1] . 5 receptors [3] [4] [5] . In animal models of pain, buspirone exerted analgesic action increasing the threshold to thermal, electrical, chemogenic, and visceral pain. The drug inhibits gastric acid secretion and exerts gastric mucosal protective and anti-inflammatory effects [6] .
Serotonin has wide distribution in the brain and gut. In brain, serotonin plays an important role in mood, behavior, aggression, and sexual function [7] .
Serotonin is decreased in depression and thus drugs which increase brain serotonergic activity eg., the serotonin reuptake inhibitors (SSRIs) are the most common agents used nowadays in treating depressive disorders [8] including depression that occurs in the course of liver disease and/or results from antiviral therapy [9] . There is also evidence involving the brain serotonergic system in the development of depression in patients with chronic liver disease [10] and in hepatic encephalopathy [11] and it is likely that changes in brain serotonin could modulate liver injury.
In the body, serotonin exists mainly in the gut, being produced by the enterochromaffin cells, whilst a small amount is present in plasma stored in platelets [12] . Studies suggested an important role for serotonin derived from platelets in liver regeneration [13, 14] and also in causing hepatic injury [15, 16] . 5-HT 2A receptors are upregulated in activated hepatic stellate cells, the principal cells mediating liver fibrosis and 5 -HT 2A antagonists inhibit activation of HSCs [17] .
In hepatocytes, 5-HT 1/2A receptors stimulate, whereas 5-HT 2B receptors inhibit glycogen synthesis [18] .
There is also a decrease in 
Materials and Methods

Animals
The study was conducted using Sprague- (0.14 ml/100 g body weight) 3 days after the first dose of CCl 4 in order to maintain the hepatic damage. A 5 th group of rats (n=6) received only the vehicle (olive oil) at 2.8 ml/kg and this is followed 3 days later by an additional dose of 1.4 ml/kg olive oil. Rats were allowed free access to food and tap water during the study. Rats were euthanized by decapitation 7 days after the first dose of CCl 4 .
Biochemical Studies
Serum liver enzymes 
Liver lipid peroxidation
The measurement of malondialdehyde (MDA) was used to determine the extent of lipid peroxidation in the liver tissue. The method used is that of Ruiz-Larrea et al. [25] . In this assay, thiobarbituric acid reactive substances (TBARS) react with thiobarbituric acid to produce TBA -MDA adduct with a red color that can be determined using spectrophotometer at 532 nm.
Liver reduced glutathione
The method used is that of Ellman 
Histopathological and Immunohistochemical
Studies
The liver sections of each rat were fixed in 
DNA Ploidy Studies
For DNA analysis, we used Feulgen stained sections countered stained with Light green. Analysis was carried out using Leica Quin 500 image cytometry (Pathology Department, NRC, Cairo). For each section (100-120) cells were randomly measured [29] .
Statistical Analysis
Data presented are means ± SE. 
Results
Biochemical Results
Serum Liver Enzymes
Results are presented in Table 1 (Table 2) .
Serum and Liver Paraoxonase-1 Activity
In rats treated with CCl 4 , the activity of PON1 in the liver and serum was significantly depressed by 38.7% and 60.6%, respectively (Table 3) . Treatment with buspirone had no significant effect on liver tissue PON1 activity.
However, significantly increased serum PON1 activity by 43.9% and 53.5% was observed after treatment with 20 and 30 mg/kg buspirone, respectively (Table 3) .
Histopathological Results
Sections from CCl 4 only-treated rats stained with
Hx & E revealed severe damage of hepatocytes and liver tissue in the form of marked vacuolar degeneration and/or acidification of many cells, congestion of blood sinusoids and cellular infiltration (Fig. 1A) . Buspirone given at 10 mg/kg showed no protection against 
DNA ploidy results
In the present study, the Qwine 500 image analyzer was used to evaluate the DNA content of Results are mean ± S.E. Six rats were used per each group. The percent change from the CCl 4 -control group is also shown in parenthesis. Data were analyzed by one way ANOVA and means of different groups were compared by Duncan's multiple range test. P < 0.05 was considered statistically significant. *: 
Discussion
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Glutathione is essential for hepatoceullar integrity. This is because cellular glutathione depletion resulted in hepatic steatosis, inflammation and cell death in mice [34] . On the other hand, the glutathione donor N-acetylcysteine was able to correct the biochemical and the pathological changes in the liver of glutathione deficient mice [35] . In this study, the increase in liver lipid peroxidation and the depletion of the liver tissue content of reduced glutathione was significantly decreased by the administration of 30 mg/kg of buspirone, possibly due to lowered level of oxidative stress by the drug.
Our results also indicated markedly increased hepatic nitric oxide content following CCl 4 administration.
In the liver, nitric oxide that is constitutively formed by the action of endothelial isoform of nitric oxide synthase (eNOS) maintains hepatic microcirculation and the integrity of endothelium. In contrast, the increased generation of nitric oxide by the inducible form of NOS (iNOS) due to the action of inflammatory cytokines contributes to hepatocyte apoptosis, liver tissue damage and fibrosis under such conditions as ischaemicreperfusion injury and also after exposure to CCl 4 [36, 37] . Moreover nitric oxide synthase inhibitors were shown to prevent hepatic necrosis and to decrease the expression of tumour necrosis factor alpha (TNF-α) and cycloozygenase-2 in liver tissue of CCl 4 treated rats [38] .
In this study, the administration of buspirone at 30 mg/ kg was associated with a significant decrease in liver Paraoxonase-1 exerts an antioxidant and antiinflammatory actions in the liver and is considered a biomarker of liver diseases [40] [41] [42] . Mice deficient in paraoxonase 1 fed high fat and cholesterol diet exhibited increased extent of fatty degeneration as well as increased lipid peroxides and oxidative stress markers relative to their wild-type counterparts on the same diet [43] . It is conceivable that the serum level of PON1 depends on the ability of the liver to synthesize the enzyme [44] . The decrease in PON1 activity observed in the current study might thus reflects decreased synthesis by the intoxicated liver cells and the recovery in PON1 could be the result of reducing oxidative stress and improving the condition of hepatocytes by buspirone treatment.
In the peripheral tissues, synthesis of serotonin is carried out by the enterochromaffin cells of the gut.
Serotonin is then released into circulation and most of this circulating serotonin is actively taken up, sequestrated within vesicles in platelets and released upon their stimulation [7, 45] . This platelet-derived serotonin has been implicated in both liver protection [46, 47] and regeneration [14, 15] but also in the development of hepatic injury [16, 17] . Thus, in the aged rat stimulation of 5-hydroxytryptamine receptor 2 resulted in improving sinusoidal perfusion and in restoring the deficit in liver regeneration via vascular endothelial growth factor [46] . In mice, absence of peripheral serotonin caused increased acetaminopheninduced liver damage [47] . Moreover, mice lacking tryptophan hydroxylase 1 which is the rate-limiting The same mechanism could possibly be also involved in their hepatic protective effects described earlier by increasing the plasma serotonin and therefore serotonin availability for liver cells. Buspirone, however, does not affect the reuptake of serotonin into platelets and in healthy subjects causes an increase in plasma levels of free serotonin without affecting platelet serotonin or platelet aggregation [51] .
In summary, the present study has demonstrated that the 5-HT 1A agonist buspirone reduced experimental liver injury induced by CCl 4 in the rat.
Buspirone displayed antioxidant action, reduced apoptosis and improved the CCl 4 -induced changes in DNA values in hepatic cells. These data suggest that the drug is safe in patients with liver disease.
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